UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - intein+splicing
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Gene Therapy for DOCK8 Deficiency (UCLA Case No. 2023-178)
UCLA researchers in the Department of Pediatrics Allergy and Immunology have developed a gene therapy method to express the full-length DOCK8 protein in cells, aimed at treating DOCK8 deficiency. These method allows for safe and effective DOCK8 expression in hematopoietic stem cells without the need for an HLA-matched donor, enabling patients to undergo...
Published: 2/18/2025
|
Inventor(s):
Caroline Kuo
Keywords(s):
bone marrow
,
bone marrow transplants
,
DOCK8
,
DOCK8 deficiency
,
Gene Editing Systems
,
Gene Therapy
,
hematopoietic stem cells
,
Immune System
,
immunodeficiency
,
Immunology
,
intein splicing
Category(s):
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Gene Therapy And Editing
,
Therapeutics > Stem Cells And Regenerative Medicine
,
Life Science Research Tools > Plasmids/Vectors